Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Acute kidney injury
What is your approach to managing AKI secondary to intravenous acyclovir?
Related Questions
In which clinical scenarios do you use prolonged intermittent renal replacement therapy (PIRRT)?
How frequently do you check serum electrolytes for patients on CRRT?
Do you recommend avoiding combination vancomycin and piperacillin-tazobactam in patients with acute kidney injury?
Would you recommend CRRT instead of intermittent hemodialysis to prevent lithium rebound in a patient with lithium toxicity after an initial intermittent hemodialysis session?
How do you approach the management of a patient with an ileostomy who has recurrent prerenal AKI episodes that improve with IV fluids but worsen with each attempt to transition to oral fluids alone?
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
How do you manage oral prednisone when initiating nefecon in a patient with IgA nephropathy?
How do you approach the workup of a patient with a large focal wedge-shaped cortical swelling on CT concerning for renal infarct, but with a normal echocardiogram showing no thrombus or vegetation?
How do you determine the optimal time to restart a diuretic in a patient with cirrhosis, ascites, and lower extremity edema who presented with acute kidney injury that resolved with IV albumin and holding diuretics?
Do you target specific Kt/V values or specific duration of hemodialysis sessions for hospitalized patients who you are planning several consecutive and progressive hemodialysis initiation sessions?
